Skip to main content

Table 1 Relationship between hsa-miR-125a-3p expression and clinical pathological factors in lung cancinoma

From: Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells

  

hsa-miR-125a-3p

Variable

Patients

Low expression(%)

High expression(%)

p value

Gender

    

Male

33

12 (36.4)

21 (63.6)

 

Female

19

6 (31.6)

13 (68.4)

0.727b

Age

    

≤ 60

28

22 (78.6)

6 (21.4)

 

> 60

24

12 (50.0)

12 (50.0)

0.031b

Histology type

    

Squamous cancer

22

13 (59.1)

9 (40.9)

 

Adenocarcinoma

30

21 (70.0)

9 (30.0)

0.414b

Pathological grade

    

I

8

7 (87.5)

1 (12.5)

 

II

28

17 (60.7)

11 (39.3)

 

III

16

10 (62.5)

6 (37.5)

0.370c

Pathological stage

    

I

18

8 (44.4)

10 (55.6)

 

II

15

10 (66.7)

5 (33.3)

 

III

19

16 (80.0)

3 (20.0)

0.012c

Lymph node status

    

No metastasis

32

17 (53.1)

15 (46.9)

 

Metastasis

20

17 (85.0)

3 (15.0)

0.034a

  1. a Two-sided Fisher's Exact Test.
  2. b Chi-square Test
  3. c Mann-whitney Test
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us